Already Had COVID-19? One Dose of Pfizer Vaccine Offers Substantial Protection

For those who have recovered from COVID-19, one dose of the Pfizer vaccine offers significant, long-lasting protection, according to two research studies recently published in The Lancet. It is thought that one dose of the Pfizer vaccine stimulates already present antibodies to SARS-CoV-2 among those who have recovered from COVID-19. Public health officials suggest that by offering individuals with antibodies one dose of the Pfizer vaccine, it will speed up efforts to get more people without antibodies vaccinated. Higher numbers of vaccinated people could help reduce risk of dangerous mutations. Click here to read more.